Study on the mechanism of Pulsatilliae Radix in the treatment of tuberculosis based on network pharmacology
LIU Yan-xia1 REN Ming-hui2 DU Bao-zhong2▲
1.Ningxia Hui Autonomous Region Hospital of Traditional Chinese Medicine and Chinese Medicine Research Institute,Ningxia Hui Autonomous Region,Yinchuan 750021,China;
2.Plateau Health Science Research Center,Tibet University,Tibet,Lhasa 850000,China
Abstract:Objective To screen the active constituents of Pulsatilliae Radix based on the method of network pharmacology,to predict the potential therapeutic targets of pulmonary tuberculosis and to explore its potential mechanism.Methods Pulsatilliae Radix ingredients,corresponding targets and target genes related to the treatment of pulmonary tuberculosis were selected from the traditional Chinese medicine systems pharmacology database and analysis platform,PubChem,Pharm Mapper,Uniprot,Gene Cards,OMIM databases.Combined with the String database and Cytoscape 3.6.1 software,the active component-target network diagram and the protein-protein interaction network for Pulsatilliae Radix tuberculosis treatment were constructed.GO enrichment analysis and KEGG signal pathway enrichment analysis of Pulsatilliae Radix tuberculosis treatment targets were performed by DAVID database and Weishengxin online mapping software.Results Using oral bioavailability and drug-like parameters as criteria,the 9 herb ingredients such as Mairin,Aureusidin,β-sitosterol,isorhamnetin,Stigmasterol, etc,were screened out.It is mainly used to treat tuberculosis by regulating potential targets such as nitric oxide synthase 2,leukotriene A4 hydrolase,peroxisome proliferators activate receptors, etc,these targets may through pathways in cancer and tumor necrosis factor signaling pathway to play to the role of the treatment of pulmonary tuberculosis.Conclusion Therefore,through the network pharmacological research,it was preliminarily predicted that Stigmasterol might be the main active ingredient of Pulsatilliae Radix in the treatment of pulmonary tuberculosis by regulating the cancer signal pathway and tumor necrosis factor signaling pathway,activating the process of apoptosis,participating in the immune response, etc,so as to make Mycobacterium tuberculosis lose living environment,play the role of treating tuberculosis thereby.
刘艳霞;任明辉;杜宝中. 基于网络药理学的白头翁治疗肺结核作用机制研究[J]. 中国当代医药, 2021, 28(27): 4-9.
LIU Yan-xia;REN Ming-hui;DU Bao-zhong. Study on the mechanism of Pulsatilliae Radix in the treatment of tuberculosis based on network pharmacology. 中国当代医药, 2021, 28(27): 4-9.
Kyriakis JM,Avruch J.Mammalian MAPK signal transduction pathways activated by stress and inflammation:a 10-year update[J].Physiol Rev,2012,92(2):689-737.
[9]
Cargnello M,Roux PP.Activation and function of the MAPKs and their substrates,the MAPK-activated protein kinases[J].Microbiol Mol Biol Rev,2012,76(2):496.
[10]
Dahl JL,Kraus CN,Boshoff HIM,et al.The role of RelMtbmediated adaptation to stationary phase in long-term persistence ofMycobacterium tuberculosisin mice[J].Proc Natl Acad Sci USA,2003,100(17):10 026-10 031.
Gudkov AV,Komarova EA.p53 and the carcinogenicity of chronic inflammation[J].Cold Spring Harb Perspect Med,2016,6(11):1-24.
[14]
Choi WH,Chu JP,Jiang MH,et al.Effects of fraction obtained from Korean Corni Fructus extracts causing anti proliferation and p53-dependent apoptosis in A549 lung cancer cells[J].Nutr Cancer,2011,63(1):121-129.
[15]
Wang H,Li WY,Lai BT,et al.A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53in vivo[J].Anti-Cancer Drugs,2015,26(8):852-859.
Li W,Zhao Q,Deng W,et al.Mycobacterium tuberculosisRv3402c enhances mycobacteria survival within macrophages and modulates the host pro-inflammatory cytokines production via NF-Kappa B/ERK/p38 signaling[J].PLoS One,2014,9(11):e94418.
[1]
World Health Organization.Global tuberculosis report 2020[R].Geneva:World Health Organization,2020.
[22]
Barham MS,Whatney WE,Khayumbi J,et al.Activation-Induced Marker Expression IdentifiesMycobacterium tuberculosis-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent Tuberculosis[J].Immunohorizons,2020,4(10):573-584.